The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...

Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that ...

The biotech company reported second-quarter financial results on Friday ahead of market open, a day after announcing plans to ...

In a striking bipartisan move, the Senate Appropriations Committee voted 26-3 to boost the NIH’s budget by $400 million — rejecting the Trump administration’s proposed $17 billion cut and sweeping ...

Friday’s announcement comes after Moderna announced a sweeping headcount reduction earlier this week that will see it slash ...

Moderna’s second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening ...

The Moderna layoffs are aimed at cutting costs amid declining vaccine sales and a shifting regulatory landscape.

Analysts expect the Cambridge, Massachusetts-based company to report quarterly loss at $2.97 per share, versus a year-ago ...

Stocks closed in the red on Thursday, with the S&P 500 logging its third straight day of losses. The broad market index ...

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...

The target is to reduce its workforce to less than 5,000 from a level of 5,800 at the end of 2024, said chief executive ...

The layoffs will affect hundreds of employees globally, though Bancel did not disclose in which areas of the business.